Barbexaclone

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Barbexaclone
Combination of
PhenobarbitalBarbiturate
PropylhexedrineStimulant (sympathomimetic)
[[{{{component3}}}]]? Class
[[{{{component4}}}]]? Class
[[{{{component5}}}]]? Class
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Barbexaclone

Articles

Most recent articles on Barbexaclone

Most cited articles on Barbexaclone

Review articles on Barbexaclone

Articles on Barbexaclone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Barbexaclone

Images of Barbexaclone

Photos of Barbexaclone

Podcasts & MP3s on Barbexaclone

Videos on Barbexaclone

Evidence Based Medicine

Cochrane Collaboration on Barbexaclone

Bandolier on Barbexaclone

TRIP on Barbexaclone

Clinical Trials

Ongoing Trials on Barbexaclone at Clinical Trials.gov

Trial results on Barbexaclone

Clinical Trials on Barbexaclone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Barbexaclone

NICE Guidance on Barbexaclone

NHS PRODIGY Guidance

FDA on Barbexaclone

CDC on Barbexaclone

Books

Books on Barbexaclone

News

Barbexaclone in the news

Be alerted to news on Barbexaclone

News trends on Barbexaclone

Commentary

Blogs on Barbexaclone

Definitions

Definitions of Barbexaclone

Patient Resources / Community

Patient resources on Barbexaclone

Discussion groups on Barbexaclone

Patient Handouts on Barbexaclone

Directions to Hospitals Treating Barbexaclone

Risk calculators and risk factors for Barbexaclone

Healthcare Provider Resources

Symptoms of Barbexaclone

Causes & Risk Factors for Barbexaclone

Diagnostic studies for Barbexaclone

Treatment of Barbexaclone

Continuing Medical Education (CME)

CME Programs on Barbexaclone

International

Barbexaclone en Espanol

Barbexaclone en Francais

Business

Barbexaclone in the Marketplace

Patents on Barbexaclone

Experimental / Informatics

List of terms related to Barbexaclone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine. It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results" had not yet been confirmed nor denied in controlled trials. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.

References

  • The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. p. 472. ISBN 0-632-06046-8


Template:Anticonvulsants Template:Stimulants